BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 17413026)

  • 1. Fibrillar and oligomeric beta-amyloid as distinct local biomarkers for Alzheimer's disease.
    Montalto MC; Farrar G; Hehir CT
    Ann N Y Acad Sci; 2007 Feb; 1097():239-58. PubMed ID: 17413026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-amyloid fibrils of Alzheimer's disease: pathologically altered, basement membrane-associated microfibrils?
    Inoue S; Kisilevsky R
    Ital J Anat Embryol; 2001; 106(2 Suppl 1):93-102. PubMed ID: 11730002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
    Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z
    Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
    Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
    Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoaspartate formation at position 23 of amyloid beta peptide enhanced fibril formation and deposited onto senile plaques and vascular amyloids in Alzheimer's disease.
    Shimizu T; Fukuda H; Murayama S; Izumiyama N; Shirasawa T
    J Neurosci Res; 2002 Nov; 70(3):451-61. PubMed ID: 12391606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid imaging in Alzheimer's disease.
    Nordberg A
    Neuropsychologia; 2008; 46(6):1636-41. PubMed ID: 18468648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease.
    Nagele RG; Wegiel J; Venkataraman V; Imaki H; Wang KC; Wegiel J
    Neurobiol Aging; 2004; 25(5):663-74. PubMed ID: 15172746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal heterogenicity of amyloid protein examined in Alzheimer's disease.
    Pirim I; Erdogan AR; Tan U
    Int J Neurosci; 2004 Jan; 114(1):75-81. PubMed ID: 14660069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The distribution of amyloid beta protein deposition in the corpus striatum of patients with Alzheimer's disease.
    Brilliant MJ; Elble RJ; Ghobrial M; Struble RG
    Neuropathol Appl Neurobiol; 1997 Aug; 23(4):322-5. PubMed ID: 9292871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular amyloid-beta in Alzheimer's disease.
    LaFerla FM; Green KN; Oddo S
    Nat Rev Neurosci; 2007 Jul; 8(7):499-509. PubMed ID: 17551515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Link between heart disease, cholesterol, and Alzheimer's disease: a review.
    Sparks DL; Martin TA; Gross DR; Hunsaker JC
    Microsc Res Tech; 2000 Aug; 50(4):287-90. PubMed ID: 10936882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid-beta aggregation.
    Finder VH; Glockshuber R
    Neurodegener Dis; 2007; 4(1):13-27. PubMed ID: 17429215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Styryl-based compounds as potential in vivo imaging agents for beta-amyloid plaques.
    Li Q; Min J; Ahn YH; Namm J; Kim EM; Lui R; Kim HY; Ji Y; Wu H; Wisniewski T; Chang YT
    Chembiochem; 2007 Sep; 8(14):1679-87. PubMed ID: 17705341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?
    Swerdlow RH
    Neurobiol Aging; 2007 Oct; 28(10):1465-80. PubMed ID: 16876913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linker histone H1 binds to disease associated amyloid-like fibrils.
    Duce JA; Smith DP; Blake RE; Crouch PJ; Li QX; Masters CL; Trounce IA
    J Mol Biol; 2006 Aug; 361(3):493-505. PubMed ID: 16854430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abundant expression of zinc transporters in the amyloid plaques of Alzheimer's disease brain.
    Zhang LH; Wang X; Stoltenberg M; Danscher G; Huang L; Wang ZY
    Brain Res Bull; 2008 Sep; 77(1):55-60. PubMed ID: 18639746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathology: Alzheimer's in real time.
    Masliah E
    Nature; 2008 Feb; 451(7179):638-9. PubMed ID: 18256653
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of molecular compounds critical to Alzheimer's-like plaque formation.
    Gellermann GP; Ullrich K; Unger C; Fändrich M; Sauter S; Diekmann S
    J Neurosci Res; 2007 Jul; 85(9):2037-44. PubMed ID: 17492785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble Abeta oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer's disease brain.
    Kokubo H; Kayed R; Glabe CG; Yamaguchi H
    Brain Res; 2005 Jan; 1031(2):222-8. PubMed ID: 15649447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein J (clusterin) and Alzheimer's disease.
    Calero M; Rostagno A; Matsubara E; Zlokovic B; Frangione B; Ghiso J
    Microsc Res Tech; 2000 Aug; 50(4):305-15. PubMed ID: 10936885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.